Advent International, a global private equity investor, has recapitalized RxBenefits, the first and only technology-enabled pharmacy benefits optimizer, and values the Birmingham-based company at $1.1 billion. The recapitalization will allow RxBenefits to expand its team and technology. Advent joins Great Hill Partners, which invested in RxBenefits in 2016. Each of these investors own an equal…
